Nadia D. Ali, MD
Associate Professor of Clinical Medicine (Hematology-Oncology)
Director of the Comprehensive Sickle Cell Program, Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Hematology/Oncology Department
Third Floor Dulles Building
3400 Spruce Street 19104
Philadelphia, PA 19140
Hematology/Oncology Department
Third Floor Dulles Building
3400 Spruce Street 19104
Philadelphia, PA 19140
Education:
BA (Biological Sciences)
Dartmouth College , 2007.
MD (Medicine )
Southern Illinois University , 2011.
Permanent linkBA (Biological Sciences)
Dartmouth College , 2007.
MD (Medicine )
Southern Illinois University , 2011.
Description of Clinical Expertise
I am board certified in Internal Medicine, Hematology and Medical Oncology. I previously was a busy clinician as a general hematologist in both malignant and non-malignant hematology at Temple/Fox Chase Cancer Center in North Philadelphia but have shifted my focus to sickle cell disease (SCD). I recently joined Penn Medicine as Director of the Comprehensive Sickle Cell Program to dedicate my career to helping people living with SCD.Description of Other Expertise
medical educationDescription of Research Expertise
My scholarly focus has shifted to classical hematology and specifically on sickle cell disease and fertility.Selected Publications
Ewy J, Senapati S, Ali ND, Gracia CR.: Special considerations in assisted reproductive technology for patients with hematologic disease. Fertil Steril. 124(2): 200-211, Aug 2025.Braun E, McVay K, Koelper N, Ali N, Gollomp K, Roe AH: Induced and spontaneous abortion outcomes among individuals with sickle cell disease. Contraception. Contraception 111052, Aug 2025.
Jian Jeff Fu , Anjali Seth, Nadia Ali, Ashwin Chandar, Ashish Bains. : ALK-positive Large B-Cell Lymphoma With Multiple Epithelial Antigen Expression and PABPC1::ALK Fusion : A Novel Molecular Alteration Am J Surg Pathol 47(8): 950-954, Aug 2023.
Stack A, Black S, Gupta B,Zhao H, Ali N.: Correlation between the 4T Score, Enzyme-Linked Immunosorbent Assay and Serotonin Release Assay for Diagnosis of Heparin Induced Thrombocytopenia. American Society of Hematology Annual Meeting, New Orleans, LA. Dec 2022 Notes: "Poster Presentation"
Yousef I, Desai PB, Sehgal S, Gupta R, Gordon M, Weir M, Ali N, Criner GJ, Rao AK, Rali P.: Thromboelastography (TEG) in COVID-19 Patients - Not All Hypercoagulable. American Thoracic Society International Conference, Virtual Meeting. May 2021 Notes: "Poster Presentation"
Berardi, GG; Rosario Vega, JA; Ali, N.: Can you Spot the Schistocytes? Pernicious Anemia with Severe B12 Deficiency Presenting as Hemolytic Anemia. Society of Hospital Medicine Conference, Philadelphia, PA. May 2021 Notes: "Poster Presentation"
Rali P, O’Corragain O, Oresanya L, Yu D, Sheriff O, Weiss R, Myers C, Desai P, Ali N, Stack A, Bromberg M, Lubitz A, Panaro J, Bashir R, Lakhter V, Caricchio R, Gupta R, Dass C, Maruti K, Lu X, Rao AK, Cohen G, Criner G, Choi E.: Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center J Vasc Surg Venous Lymphat Disord 9(3): 585-591, May 2021.
Stack A, Ali N, Khan N.: Breast Implant-associated Anaplastic Large Cell Lymphoma: A Review with Emphasis on the Role of Brentuximab Vedotin. J Cell Immunol 2(3): 80-89, May 2020.
Ali ND and Bains A.: Triple hit B-cell lymphoma with diffuse kidney involvement sparing the glomeruli. Blood 134(10): 842. doi: 10.1182/blood.2019001752. Sep 2019.
Ali ND, Donohue K, Zandieh S, Chen C, Moore D, Poplin E, Shah MM, Nosher J, Gui B, Jabbour SK, Spencer K, Carpizo DR.: Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living 24 Months: A Single Institutional Study. Am J Clin Oncol 42(6): 512-518, Jun 2019.